Clinical Characteristics | Frequency (percent) |
---|---|
Year of publication | |
 - ≤ 2010 | 38 (50) |
 - > 2010 | 38 (50) |
Age, mean (SD) | 30.1 (11.5) |
Impaired consciousness | |
 - Yes | 21 (27.6) |
 - No | 25 (22.4) |
Pulmonary edema | |
 - Yes | 3 (3.9) |
 - No | 73 (96.1) |
Renal failure | |
 - Yes | 28 (36.8) |
 - No | 48 (63.2) |
Severe anemia | |
 - Yes | 8 (10.5) |
 - No | 68 (89.5) |
Bleeding | |
 - Yes | 8 (10.5) |
 - No | 68 (89.5) |
Jaundice | |
 - Yes | 19 (25) |
 - No | 57 (75) |
Acidosis | |
 - Yes | 4 (5.3) |
 - No | 72 (94.7) |
Hyperparasitemia | |
 - Yes | 2 (2.6) |
 - No | 74 (97.4) |
Respiratory distress | |
 - Yes | 22 (28.9) |
 - No | 54 (71.1) |
Convulsion | |
 - Yes | 8 (10.5) |
 - No | 68 (89.5) |
Prostration | |
 - Yes | 1 (1.3) |
 - No | 75 (98.7) |
Gender | |
 - Male | 48 (64) |
 - Female | 27 (36) |
Country of infection | |
 - India | 59 (77.6) |
 - Non-India | 17 (22.4) |
Days of fever | 5.71 (2.58) |
Cough | |
 - Yes | 6 (7.9) |
 - No | 70 (92.1) |
Weakness | |
 - Yes | 9 (11.8) |
 - No | 67 (88.2) |
Headache | |
 - Yes | 12 (15.8) |
 - No | 64 (84.2) |
Malaise | |
 - Yes | 3 (3.9) |
 - No | 73 (96.1) |
Rash | |
 - Yes | 7 (9.2) |
 - No | 69 (90.8) |
Urine output abnormality | |
 - Yes | 19 (25) |
 - No | 57 (75) |
Chills | |
 - Yes | 36 (47.4) |
 - No | 40 (52.6) |
Rigors | |
 - Yes | 27 (35.5) |
 - No | 49 (64.5) |
Abdominal pain | |
 - Yes | 15 (19.7) |
 - No | 61 (80.3) |
Nausea | |
 - Yes | 6 (7.9) |
 - No | 70 (92.1) |
Vomiting | |
 - Yes | 15 (19.7) |
 - No | 61 (80.3) |
Edema | |
 - Yes | 1 (1.3) |
 - No | 75 (98.7) |
Temperature, mean (SD) | 38.5 (1.04) |
Systolic blood pressure, mean (SD) | 107.6 (24.5) |
Diastolic blood pressure, mean (SD) | 69 (15.9) |
Pulse rate, mean (SD) | 110.9 (19.9) |
Respiratory rate, mean (SD) | 30.3 (11.5) |
Splenomegaly | |
 - Yes | 23 (30.3) |
 - No | 53 (69.7) |
Hepatomegaly | |
 - Yes | 17 (22.4) |
 - No | 59 (77.6) |
Hemoglobin, mean (SD) | 9.47 (2.79) |
Leukocyte, mean (SD) | 6237.8 (2722.2) |
Platelet, mean (SD) | 85,360 (74,296.5) |
RDT | |
 - Yes | 43 (56.6) |
 - No | 33 (43.4) |
Time point of severe complications | |
 - Before treatment (at presentation) | 50 (65.8) |
 - After treatment (with anti-malarial drug) | 16 (21.1) |
 - Before and after treatment | 10 (13.2) |
Complication during treatment | |
 - Yes | 34 (44.7) |
 - No | 42 (55.3) |
Second anti-malarial drug given | |
 - Yes | 13 (17.1) |
 - No | 63 (82.9) |
Discharge/recovery/parasite clearance | |
 - > 7 days | 41 (65.1) |
 - ≤ 7 days | 22 (34.9) |